相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
Alexandre O. Gerard et al.
JOURNAL OF HEADACHE AND PAIN (2022)
Hypertension: A new safety risk for patients treated with erenumab
Suprat Saely et al.
HEADACHE (2021)
New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database
Maurizio Sessa et al.
BIODRUGS (2021)
Vascular safety of erenumab for migraine prevention
David Kudrow et al.
NEUROLOGY (2020)
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Stewart J. Tepper et al.
CEPHALALGIA (2020)
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
Tessa de Vries et al.
PHARMACOLOGY & THERAPEUTICS (2020)
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancilla et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
Stephen Aradi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects
Zizheng Kee et al.
FRONTIERS IN PHYSIOLOGY (2018)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension
I. Marquez-Rodas et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2006)
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache
L Edvinsson
CEPHALALGIA (2004)
An immunocytochemical investigation of human trigeminal nucleus caudalis:: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres
D Smith et al.
CEPHALALGIA (2002)